Skip to main content
. 2019 Oct 14;9(10):e029542. doi: 10.1136/bmjopen-2019-029542

Table 3.

Multiple linear regression analyses of the relationship between sociodemographic and disease variables with the signalling questions (n=1060)

Fatigue* Hand function and mobility† Sleep problems‡ Emotions and stress§ Body image¶ Pain** Self-management Nutrition and diet†† Exercise‡‡
β (p value) β (p value) β (p value) β (p value) β (p value) β (p value) β (p value) β (p value) β (p value)
Age in years 0.05 (0.03) 0.02 (0.41) 0.08 (<0.01) −0.08 (<0.01) −0.05 (0.02) 0.01 (0.70) 0.03 (0.18) <−0.01 (0.95) 0.01 (0.73)
Male sex 0.06 (<0.01) 0.02 (0.43) 0.01 (0.60) −0.02 (0.26) −0.03 (0.11) 0.04 (0.03) <0.01 (0.84) −0.05 (0.01) −0.02 (0.31)
Disease duration −0.02 (0.44) −0.01 (0.58) <−0.01 (0.94) −0.03 (0.10) −0.02 (0.35) 0.01 (0.47) −0.01 (0.78) −0.02 (0.36) <−0.01 (0.98)
Diffuse disease −0.05 (0.02) 0.02 (0.31) −0.04 (0.08) −0.02 (0.42) 0.01 (0.63) −0.03 (0.19) 0.02 (0.34) −0.01 (0.62) 0.03 (0.27)
Education in years <0.01 (0.87) <−0.01 (0.99) 0.03 (0.10) 0.01 (0.60) −0.06 (0.01) −0.05 (<0.01) −0.01 (0.47) 0.06 (0.01) 0.07 (<0.01)
Married or living as married 0.03 (0.21) 0.03 (0.19) <−0.01 (0.95) −0.04 (0.03) <0.01 (0.88) 0.02 (0.43) 0.01 (0.45) −0.01 (0.61) −0.01 (0.69)
Self-efficacy 0.10 (<0.01) 0.11 (<0.01) 0.13 (<0.01) 0.03 (0.13) 0.09 (<0.01) 0.04 (0.05) −0.03 (0.12) 0.09 (<0.01) 0.16 (<0.01)
Symptom measure 0.30 (<0.01) 0.21 (<0.01) 0.43 (<0.01) 0.18 (<0.01) 0.28 (<0.01) 0.32 (<0.01) 0.07 (<0.01) −0.04 (0.13)
Mean of remaining signalling items 0.65 (<0.01) 0.63 (<0.01) 0.61 (<0.01) 0.72 (<0.01) 0.64 (<0.01) 0.67 (<0.01) 0.80 (<0.01) 0.71 (<0.01) 0.70 (<0.01)
R2 0.58 0.47 0.61 0.62 0.55 0.64 0.64 0.51 0.46

β: standardised regression coefficient.

*Symptom measures for the models: PROMIS-29 fatigue.

†Symptom measures for the models: Cochin Hand Function.

‡Symptom measures for the models; PROMIS-29 sleep.

§Symptom measures for the models: PROMIS-29 depression.

¶Symptom measures for the models: SAAS score.

**Symptom measures for the models: PROMIS-29 pain.

††Symptom measures for the models: interference of gastro-intestinal symptoms.

‡‡Symptom measures for the models: activity level.

PROMIS-29, Patient-Reported Outcomes Measurement Information System-29.